Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alvaro Cobo-Calvo

Showing results (11-20 of 50) with videos related to

Pageof 5
Sort By:
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2014
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the diseaseRomana Höftberger, María Sepulveda, Thaís Armangue, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosisJose E Martínez-Rodríguez, Alvaro Cobo-Calvo, Luisa M Villar, et al.
Neurology|January 17, 2025
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MSRené Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2021
Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosisSusana Otero-Romero, Pere Carbonell-Mirabent, Luciana Midaglia, et al.
Annals of Neurology|April 5, 2014
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitisMaarten J Titulaer, Romana Höftberger, Takahiro Iizuka, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 11, 2024
Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJavier Villacieros-Álvarez, Jan D Lunemann, Maria Sepulveda, et al.
Neurology|September 15, 2021
Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated SyndromeMar Tintore, Alvaro Cobo-Calvo, Pere Carbonell, et al.
Journal of Neurology|January 10, 2022
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centreAlvaro Cobo-Calvo, Ana Zabalza, Jordi Río, et al.
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Journal of Neurology|February 14, 2019
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Pageof 5

Showing results (11-20 of 50) with videos related to

Sort By:
Pageof 5
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 26, 2014
Antibodies to MOG and AQP4 in adults with neuromyelitis optica and suspected limited forms of the diseaseRomana Höftberger, María Sepulveda, Thaís Armangue, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 13, 2015
Adaptive natural killer cell response to cytomegalovirus and disability progression in multiple sclerosisJose E Martínez-Rodríguez, Alvaro Cobo-Calvo, Luisa M Villar, et al.
Neurology|January 17, 2025
Effect of the Number of Vaccine Doses Before Starting Anti-CD20 Therapy on Seroprotection Rates Against Hepatitis B Virus in People With MSRené Carvajal, David Guananga-Álvarez, Carmen Tur, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|November 29, 2021
Oral contraceptives do not modify the risk of a second attack and disability accrual in a prospective cohort of women with a clinically isolated syndrome and early multiple sclerosisSusana Otero-Romero, Pere Carbonell-Mirabent, Luciana Midaglia, et al.
Annals of Neurology|April 5, 2014
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitisMaarten J Titulaer, Romana Höftberger, Takahiro Iizuka, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|December 11, 2024
Complement Activation Profiles Predict Clinical Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseJavier Villacieros-Álvarez, Jan D Lunemann, Maria Sepulveda, et al.
Neurology|September 15, 2021
Effect of Changes in MS Diagnostic Criteria Over 25 Years on Time to Treatment and Prognosis in Patients With Clinically Isolated SyndromeMar Tintore, Alvaro Cobo-Calvo, Pere Carbonell, et al.
Journal of Neurology|January 10, 2022
Impact of COVID-19 pandemic on frequency of clinical visits, performance of MRI studies, and therapeutic choices in a multiple sclerosis referral centreAlvaro Cobo-Calvo, Ana Zabalza, Jordi Río, et al.
Neurology|March 6, 2024
Trans-Synaptic Degeneration in the Visual Pathway in Patients With Myelin Oligodendrocyte Glycoprotein Antibody-Associated DiseaseLuca Bollo, Georgina Arrambide, Alvaro Cobo-Calvo, et al.
Journal of Neurology|February 14, 2019
Correction to: Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adultsAlvaro Cobo-Calvo, María Sepúlveda, Hyacintha d'Indy, et al.
Pageof 5